Pasar al contenido principal

ESTUDIO DE LAS DIFERENCIAS DE SEXO EN ENFERMEDADES NEURODEGENERATIVAS CON ABORDAJES INTEGRATIVOS DE DATOS OMICOS E IMAGEN BIOMEDICA

PID2021-124430OA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACIÓN DE LA COMUNIDAD VALENCIANA CENTRO DE INVESTIGACION PRÍNCIPE FELIPE

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

The role of microRNAs in understanding sex-based differences in Alzheimer s disease

  • Llera&#8209
  • Oyola, Jaime
  • Carceller, Héctor
  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Soler-Sáez, Irene
  • Gordillo-González, Fernando
  • Gómez-Cabañes, Borja
  • Rosón, Beatriz
  • Mancuso, Roberta
  • Guerini, Franca R.
  • Mizokami, Akiko
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Background: The incidence of Alzheimer's disease (AD)-the most frequent cause of dementia-is expected to increase as life expectancies rise across the globe. While sex-based differences in AD have previously been described, there remain uncertainties regarding any association between sex and disease-associated molecular mechanisms. Studying sex-specific expression profiles of regulatory factors such as microRNAs (miRNAs) could contribute to more accurate disease diagnosis and treatment.Methods: A systematic review identified six studies of microRNA expression in AD patients that incorporated information regarding the biological sex of samples in the Gene Expression Omnibus repository. A differential microRNA expression analysis was performed, considering disease status and patient sex. Subsequently, results were integrated within a meta-analysis methodology, with a functional enrichment of meta-analysis results establishing an association between altered miRNA expression and relevant Gene Ontology terms.Results: Meta-analyses of miRNA expression profiles in blood samples revealed the alteration of sixteen miRNAs in female and 22 miRNAs in male AD patients. We discovered nine miRNAs commonly overexpressed in both sexes, suggesting a shared miRNA dysregulation profile. Functional enrichment results based on miRNA profiles revealed sex-based differences in biological processes; most affected processes related to ubiquitination, regulation of different kinase activities, and apoptotic processes in males, but RNA splicing and translation in females. Meta-analyses of miRNA expression profiles in brain samples revealed the alteration of six miRNAs in female and four miRNAs in male AD patients. We observed a single underexpressed miRNA in female and male AD patients (hsa-miR-767-5p); however, the functional enrichment analysis for brain samples did not reveal any specifically affected biological process.Conclusions: Sex-specific meta-analyses supported the detection of differentially expressed miRNAs in female and male AD patients, highlighting the relevance of sex-based information in biomedical data. Further studies on miRNA regulation in AD patients should meet the criteria for comparability and standardization of information., This research was supported by and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by ERDF, "A way to make Europe", PID2021-124430OA-I00 funded by MCIN/AEI/10.13039/501100011033 and by "ERDFA way to make Europe". HC is supported by a postdoctoral "Margarita Salas" grant (MS21-074) from the Universitat de Valencia funded by the Spanish Ministry of Science and the Next Generation EU.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases

  • Soler-Sáez, Irene
  • Alcida Karz
  • Hidalgo, Marta R.
  • Gómez-Cabañes, Borja
  • López-Cerdán, Adolfo
  • Català-Senent, José F.
  • Prutisto-Chang, Kylie
  • Eskow, Nicole M.
  • Izar, Benjamin
  • Redmer, Torben
  • Kumar, Swaminathan
  • Davis, Michael A.
  • Hernando, Eva
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Melanoma represents a critical clinical challenge owing to its unfavorable outcomes. This type of skin cancer exhibits unique adaptability to the brain microenvironment, but its underlying molecular mechanisms are poorly understood. Recent findings have suggested that melanoma brain metastases may share biological processes similar to those found in various neurodegenerative diseases. To further characterize melanoma brain metastasis development, we explore the relationship between the transcriptional profiles of melanoma brain metastases and the neurodegenerative diseases Alzheimer's disease, Parkinson's disease, and multiple sclerosis. We take an in silico approach to unveil a neurodegenerative signature of melanoma brain metastases compared with those of melanoma nonbrain metastasis (53 dysregulated genes were enriched in 11 functional terms, such as associated terms to the extracellular matrix and development) and with those of nontumor-bearing brain controls (195 dysregulated genes, mostly involved in development and cell differentiation, chromatin remodeling and nucleosome organization, and translation). Two genes, ITGA10 and DNAJC6, emerged as key potential markers being dysregulated in both scenarios. Finally, we developed an open-source, user-friendly web tool (https://bioinfo.cipf.es/metafun-mbm/) that allows interactive exploration of the complete results., The authors thank the Principe Felipe Research Center for providing access to the cluster, cofunded by European Regional Development Funds to the Valencian Community 2014-2020. This research was supported and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019) , cofunded by ERDF, "A way to make Europe", PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033, and by European Regional Development Fund. IS-S is supported by a predoctoral grant FPU20/03544 funded by the Spanish Ministry of Universities. BG-C is supported by a PhD fellowship funded by the Spanish Association Against Cancer in Valencia (PRDVA234163GOME) . MAD is supported by the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the AIM at Melanoma Foundation, the National Institutes of Health/National Cancer Insititute P50CA221703, the American Cancer Society and the Melanoma Research Alliance, Cancer Fighters of Houston, the Anne and John Mendelsohn Chair for Cancer Research, and philanthropic contributions to the Melanoma Moon Shots Program of MD Anderson. We also thank the authors of the previous publications (PMID: 30787016; PMID: 35803246; PMID: 36435874) for their commitment to open science by depositing the data in public repositories, making the data available and reusable. FG-G is the guarantor of this work.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Deciphering the sex bias in housekeeping gene expression in adipose tissue: a comprehensive meta-analysis of transcriptomic studies

  • Guaita Cespedes, María
  • Grillo-Risco, Rubén
  • Hidalgo, Marta R.
  • Fernández-Veledo, Sonia
  • Burks, Deborah Jane
  • Galán, Amparo
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Background: As the housekeeping genes (HKG) generally involved in maintaining essential cell functions are typically assumed to exhibit constant expression levels across cell types, they are commonly employed as internal controls in gene expression studies. Nevertheless, HKG may vary gene expression profile according to different variables introducing systematic errors into experimental results. Sex bias can indeed affect expression display, however, up to date, sex has not been typically considered as a biological variable. Methods: In this study, we evaluate the expression profiles of six classical housekeeping genes (four metabolic: GAPDH, HPRT, PPIA, and UBC, and two ribosomal: 18S and RPL19) to determine expression stability in adipose tissues (AT) of Homo sapiens and Mus musculus and check sex bias and their overall suitability as internal controls. We also assess the expression stability of all genes included in distinct whole-transcriptome microarrays available from the Gene Expression Omnibus database to identify sex-unbiased housekeeping genes (suHKG) suitable for use as internal controls. We perform a novel computational strategy based on meta-analysis techniques to identify any sexual dimorphisms in mRNA expression stability in AT and to properly validate potential candidates. Results: Just above half of the considered studies informed properly about the sex of the human samples, however, not enough female mouse samples were found to be included in this analysis. We found differences in the HKG expression stability in humans between female and male samples, with females presenting greater instability. We propose a suHKG signature including experimentally validated classical HKG like PPIA and RPL19 and novel potential markers for human AT and discarding others like the extensively used 18S gene due to a sex-based variability display in adipose tissue. Orthologs have also been assayed and proposed for mouse WAT suHKG signature. All results generated during this study are readily available by accessing an open web resource (https://bioinfo.cipf.es/metafun-HKG) for consultation and reuse in further studies. Conclusions: This sex-based research proves that certain classical housekeeping genes fail to function adequately as controls when analyzing human adipose tissue considering sex as a variable. We confirm RPL19 and PPIA suitability as sex-unbiased human and mouse housekeeping genes derived from sex-specific expression profiles, and propose new ones such as RPS8 and UBB., This research was supported by and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, A way to make Europe ), PID2021-124430OA-I00 funded by MCIN/AEI//501100011033/FEDER, UE ( A way to make Europe ), and SAF2017-84708-R grants. M.G. is the recipient of ACIF/2021/196 predoctoral fellowship
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Multi-omics factor analysis v2 (MOFA+) reveals specific co-variation patterns in women with PMOS that are strongly influenced by obesity

  • Géraud-Aguilar, Edmond
  • Martinez-Garcia, M. Angeles
  • Insenser, Maria
  • Luque-Ramirez, Manuel
  • Garcia-Garcia, Francisco
  • Escobar-Morreale, Hector F.
  • Barceló-Cerdá, Susana|||0000-0001-5110-6698
[EN] STUDY QUESTION What are the mechanisms underlying the complex interactions between polyendocrine metabolic ovarian syndrome (PMOS) and obesity as studied by a multi-omics integration approach? SUMMARY ANSWER Multi-Omics Factor Analysis v2 (MOFA+) suggested that PMOS was characterized by an androgen-driven metabolic reprogramming in which sexual dimorphism was reshaped in an obesity-and omics-specific manner, consisting of strong associations of proinflammatory proteins and adipokines with gut microbiota genera and metabolomics variables that were amplified by obesity. WHAT IS KNOWN ALREADY PMOS is a common metabolic-endocrine disorder in which androgen excess, weight excess, and obesity complex interactions define a particularly unfavorable cardiometabolic phenotype. STUDY DESIGN, SIZE, DURATION Cross-sectional study with 2 control groups involving 46 Caucasian young adults, conducted at an academic hospital in Madrid, Spain. PARTICIPANTS/MATERIALS, SETTING, METHODS We recruited 15 women with PMOS, 16 healthy control women, and 15 control men of similar mean age and BMI. Participants were further grouped into non-obese (BMI < 30 kg/m & sup2;) or obese (BMI >= 30 kg/m & sup2;) subjects. We integrated serum metabolomics and circulating proteins with gut microbiota composition, using MOFA+. MAIN RESULTS AND THE ROLE OF CHANCE MOFA+ identified five latent factors explaining the main sources of variation across omics layers. Results showed sexual dimorphism in an omics-and obesity-specific manner: the metabolomics profile presented sexual dimorphism in non-obese individuals, whereas circulating proteins and gut microbiota differed between women with or without PMOS and men only in obese subjects. Correlation analyses revealed a global weakening of associations in men, particularly among metabolites, a reinforcement of protein-related associations with obesity, and a distinct PMOS-specific pattern characterized by strengthened correlations within and between gut microbiota and proteomic features. Women with PMOS exhibited the strongest metabolomics-proteomics correlations, further exacerbated by obesity. LIMITATIONS, REASONS FOR CAUTION The relatively small sample size of our study might have missed relevant associations that could have reached statistical significance in larger samples. Also, we only included women with hyperandrogenic phenotypes of PMOS. Hence, our results may not apply to non-hyperandrogenic phenotypes of the syndrome. WIDER IMPLICATIONS OF THE FINDINGS PMOS showed a metabolic profile similar to that of obesity even in the absence of excess weight, supporting the concept that adipose tissue dysfunction, proinflammatory proteins, and adipokines, rather than fat mass excess per se, were a central driver of the metabolic disturbances of the syndrome. Altogether, these findings highlight the complex interplay between androgen excess, adiposity, and host-microbiota interactions and provide a systems-level framework that may facilitate the identification of novel biomarkers and targeted therapeutic strategies in PMOS. Also, these findings highlight the importance of considering sex, sex hormones, and obesity-specific contexts in biomarker discovery and mechanistic studies., This research was funded by Instituto de Salud Carlos III grants PI11/0357, PI18/01122, PI21/00116 and PI25/00434 and co-funded by the European Union. F.G.-G. was supported by CIAICO/2023/149 and funded by the Conselleria de Educacion, Cultura y Universidades de la Generalitat Valenciana, and PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033 and by ERDF/EU. CIBERDEM and IRYCIS are also an initiative of Instituto de Salud Carlos III. The funding organizations played no role in the study design; collection, analysis, and interpretation of data; the writing of the report; or the decision to submit the report for publication.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments

  • Pérez-Díez, Irene
  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Perpiñá-Clérigues, Carla
  • Fantín, Lucía
  • Fernández-Serra, Antonio
  • López-Guerrero, José A.
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Pancreatic ductal adenocarcinoma (PDAC) prognoses and treatment responses remain devastatingly poor due partly to the highly heterogeneous, aggressive, and immunosuppressive nature of this tumor type. The intricate relationship between the stroma, inflammation, and immunity remains vaguely understood in the PDAC microenvironment. Here, we performed a meta-analysis of stroma-, and immune-related gene expression in the PDAC microenvironment to improve disease prognosis and therapeutic development. We selected 21 PDAC studies from the Gene Expression Omnibus and ArrayExpress databases, including 922 samples (320 controls and 602 cases). Differential gene enrichment analysis identified 1153 significant dysregulated genes in PDAC patients that contribute to a desmoplastic stroma and an immunosuppressive environment (the hallmarks of PDAC tumors). The results highlighted two gene signatures related to the immune and stromal environments that cluster PDAC patients into high- and low-risk groups, impacting patients¿ stratification and therapeutic decision making. Moreover, HCP5, SLFN13, IRF9, IFIT2, and IFI35 immune genes are related to the prognosis of PDAC patients for the first time., This research was supported by and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, A way to make Europe ), and PID2021-124430OA-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE ( A way to make Europe ). This work has been carried out under the framework of the ULISES project: H2020-FETOPEN-2018-2019-2020-01 Contract nº: 899708.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Study of Molecular Bases Behind Sex Differences in Non-Alcoholic Fatty Liver Disease and Multiple Sclerosis through Transcriptomic Meta-Analysis

  • Català Senent, José Francisco
[ES] Las diferencias de sexo en salud son uno de los mayores sesgos existentes en la medicina actual. Tradicionalmente se han usado machos como modelo en investigación y en medicina, obviando que el desarrollo, los síntomas y la respuesta frente a una patología no es necesariamente igual en ambos sexos. En este contexto, esta tesis doctoral ha contribuido en la reducción del sesgo de sexo en medicina, estudiando las bases moleculares alteradas en función del sexo en dos enfermedades con un importante impacto en la población. Las patologías seleccionadas fueron la enfermedad del hígado graso no alcohólico (NAFLD) y la esclerosis múltiple (MS). El NAFLD comprende un abanico de alteraciones hepáticas que comienza con una acumulación de grasa en los hepatocitos (NAFL) y avanza con la aparición de inflamación (NASH), pudiendo desembocar en pérdida de la función hepática y cáncer. Los últimos estudios estiman una prevalencia global de la enfermedad alrededor del 30%, siendo mayor en hombres que en mujeres. Dentro de las mujeres, se observa una prevalencia inferior en las mujeres premenopáusicas, mientras que tras la menopausia esta se iguala con la de los hombres. Por otro lado, la MS es una enfermedad crónica autoinmune, inflamatoria y degenerativa del sistema nervioso central. Esta patología presenta distintas formas y estadios, pudiendo, en los casos más graves, afectar notablemente la calidad de vida de quienes la padecen. Como es habitual en las enfermedades neurodegenerativas, la MS presenta una mayor prevalencia en mujeres que en hombres, siendo principalmente diagnosticada en adultos jóvenes. En el trabajo de NAFLD se seleccionaron 7 estudios, incluyendo 323 pacientes. Los metaanálisis identificaron mecanismos moleculares significativamente sobreexpresados en las mujeres premenopáusicas frente a los hombres, incluyendo procesos asociados con la regulación del ADN, la unión de vinculina, las respuestas a la interleucina-2 (IL-2), la regulación negativa de la muerte neuronal y, el transporte de iones y cationes. En los hombres, descubrimos la sobrerrepresentación de genes asociados con la regulación negativa de la interleucina-6 (IL-6) y el establecimiento de la polaridad planar implicada en el cierre del tubo neural. Las diferencias en la respuesta inmunitaria observadas entre hombres y mujeres premenopáusicas en el paso de NAFL a NASH sugieren el papel de las IL-2 e IL-6 en la progresión diferencial del NAFLD en función del sexo. Por otro lado, en el capítulo sobre la MS se revisaron 122 publicaciones, de las cuales 9 cumplieron con los criterios definidos (5 de muestras de sangre y 4 de muestras de tejido cerebral), incluyendo un total de 474 individuos. Los metaanálisis de sangre y tejido cerebral identificaron, respectivamente, 1 y 13 genes asociados a la MS alterados de forma distinta entre hombres y mujeres. En el caso de los análisis funcionales en el cerebro se detectaron, entre otros, patrones inmunitarios asociados al sexo. En mujeres se observó una mayor afectación del entorno proinflamatorio y las respuestas inmunitarias innatas relacionadas con el linaje mieloide, mientras que las respuestas adaptativas se vieron más afectadas en los hombres. En conjunto, los resultados de esta disertación reafirman la utilidad de la estrategia de revisión sistemática y metaanálisis como una herramienta para la reutilización de datos publicados en abierto. En este caso, la aplicación de esta metodología nos ha permitido detectar un conjunto de alteraciones moleculares afectadas de distinta forma entre mujeres y hombres, tanto en NAFLD como en la MS. Particularmente, es destacable la presencia de cambios asociados a las interleucinas 2 y 6 en ambas enfermedades, lo cual resalta el papel que el sistema inmune juega en las alteraciones asociadas el sexo. Los resultados de este trabajo abren la puerta a investigaciones más profundas que permitan trasladar estos resultados a la práctica clínica., [CA] Les diferències de sexe en salut són un dels majors biaixos existents en la medicina actual. Tradicionalment s'han usat mascles com a model en investigació i en medicina, obviant que el desenvolupament, els símptomes i la resposta enfront d'una patologia no és necessàriament igual en tots dos sexes. En aquest context, aquesta tesi doctoral ha contribuït en la reducció del biaix de sexe en medicina estudiant les bases moleculars alterades en funció del sexe en dues malalties amb un important impacte en la població. Les patologies seleccionades van ser la malaltia del fetge gras no alcohòlic (NAFLD) i l'esclerosi múltiple (MS). El NAFLD comprén un ventall d'alteracions hepàtiques que comença amb una acumulació de greix als hepatòcits (NAFL) i avança amb l'aparició d'inflamació (NASH), podent desembocar en pèrdua de la funció hepàtica i càncer. Els últims estudis estimen una prevalença global de la malaltia al voltant del 30%, sent major en homes que en dones. Dins de les dones, s'observa una prevalença inferior en les dones premenopàusiques, mentre que després de la menopausa aquesta s'iguala amb la dels homes. Aquesta alta prevalença de la patologia fa del NAFLD un problema mundial i la malaltia hepàtica més comuna als països desenvolupats. D'altra banda, la MS és una malaltia crònica autoimmune, inflamatòria i degenerativa del sistema nerviós central. Aquesta patologia presenta diferents formes i estadis podent, en els casos més greus, afectar greument la qualitat de vida dels qui la pateixen. Com és habitual en les malalties neurodegenatives, la MS presenta una major prevalença en dones que en homes, sent principalment diagnosticada en adults joves. En el treball de NAFLD es van seleccionar 7 estudis, incloent 323 pacients. Els metaanàlisis van identificar mecanismes moleculars significativament sobreexpressats en les dones premenopàusiques enfront dels homes, incloent processos associats amb la regulació de l'ADN, la unió de vinculina, les respostes a la interleucina-2 (IL-2), la regulació negativa de la mort neuronal i el transport d'ions i cations. En els homes, descobrim la sobrerepresentació de gens associats amb la regulació negativa de la interleucina-6 (IL-6) i l'establiment de la polaritat planar implicada en el tancament del tub neural. Les diferències en la resposta immunitària observades entre homes i dones premenopàusiques en el pas de NAFL a NASH suggereixen el paper de les IL-2 i IL-6 en la progressió diferencial del NAFLD en funció del sexe. D'altra banda, en el capítol sobre la MS es van revisar 122 publicacions, de les quals 9 van complir amb els criteris definits (5 de mostres de sang i 4 de mostres de teixit cerebral), incloïen un total de 474 individus. Els metaanàlisis de sang i teixit cerebral van identificar, respectivament, 1 i 13 gens associats a la MS alterats de manera diferent entre homes i dones. En el cas dels anàlisis funcionals en el cervell es van detectar, entre altres, patrons immunitaris associats al sexe. En dones es va observar una major afectació de l'entorn proinflamatori i les respostes immunitàries innates relacionades amb el llinatge mieloide, mentre que les respostes adaptatives es van veure més afectades en els homes. En conjunt, els resultats d'aquesta dissertació reafirmen la utilitat de l'estratègia de revisió sistemàtica i *metaanálisis com una eina per a la reutilització de dades publicades en obert. En aquest cas, l'aplicació d'aquesta metodologia ens ha permés detectar un conjunt d'alteracions moleculars afectades de distinta forma entre dones i homes, tant en *NAFLD com en la MS. Particularment, és destacable la presència de canvis associats a les interleucines 2 i 6 en totes dues malalties, la qual cosa ressalta el paper que el sistema immune juga en les alteracions associades el sexe. Els resultats d'aquest treball obrin la porta a investigacions més profundes que permeten traslladar aquests resultats a la pràctica clínica., [EN] Sex differences in health are one of the primary biases in medicine today. Traditionally, males have been used as models in research and medicine, ignoring the fact that the development, symptoms, and response to a pathology are not necessarily the same in both sexes. Fortunately, in recent decades, researchers and institutions have made significant advances to reduce this bias, with the aim of providing more efficient treatment of diseases. In this context, this doctoral thesis has contributed in reducing sex bias in medicine by studying the molecular basis of sex-related alterations in two diseases with a significant impact on the population: non-alcoholic fatty liver disease (NAFLD) and multiple sclerosis (MS). NAFLD comprises a range of liver disorders that begin with an accumulation of fat in the hepatocytes (NAFL) and progress to the development of inflammation (NASH), which can lead to loss of liver function and cancer. The latest studies estimate the overall prevalence of the disease at around 30% (with an upward trend), being higher in men (40%) than in women (26%). Among women, a lower prevalence is observed in premenopausal women, while after menopause, it is equal to that of men. This high prevalence of the pathology makes NAFLD a worldwide problem and the most common liver disease in developed countries. On the other hand, MS is a chronic autoimmune, inflammatory, and degenerative disease of the central nervous system. This pathology presents different forms and stages and can, in the most severe cases, seriously affect the quality of life of those who suffer from it. As is usual in neurodegenerative diseases, MS is more prevalent in women than in men and is mainly diagnosed in young adults. In the NAFLD work, 7 studies, including 323 patients, were selected from the 114 baseline work. Meta-analyses identified molecular mechanisms significantly overexpressed in premenopausal women versus men, including processes associated with DNA regulation, vinculin binding, responses to interleukin-2 (IL-2), negative regulation of neuronal death, and ion and cation transport. In males, we discovered an overrepresentation of genes associated with negative regulation of interleukin-6 (IL-6) and the establishment of planar polarity involved in neural tube closure. The differences in immune response observed between premenopausal men and women in the transition from NAFL to NASH suggest the role of IL-2 and IL-6 in the differential progression of NAFLD as a function of sex. On the other hand, in the chapter on MS, 122 publications were reviewed, of which 9 met the defined criteria. These 9 studies (5 of blood samples and 4 of brain tissue samples) included 474 individuals. The blood and brain tissue meta-analyses identified, respectively, 1 and 13 MS-associated genes altered differently between men and women. In the case of functional analyses in the brain, sex-associated immune patterns were detected, among others. Women were more affected in the proinflammatory environment and innate immune responses related to the myeloid lineage, whereas adaptive responses were more affected in men. Overall, the results of this dissertation reaffirm the usefulness of the systematic review and meta-analysis strategy as a tool for the reuse of openly published data. In this case, the application of this methodology has allowed us to detect a set of molecular alterations affected differently between women and men in both non-alcoholic fatty liver disease and multiple sclerosis. Particularly noteworthy is the presence of changes associated with interleukins 2 and 6 in both diseases, which highlights the role that the immune system plays in sex-associated alterations. The results of this work open the door to further research to translate these results into clinical practice., This research was supported by grants from GV/2020/186 and ISCIII PT17/0009/0015 FEDER. This research was supported by and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), cofunded by the European Union, European Regional Development Fund (ERDF, "A way to make Europe"), PID2021-124430OA-I00 funded by MCIN/AEI/10.13039/501100011033/ FEDER, UE ("A way to make Europe").
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Sex differences in the neuroinflammatory signaling pathway: effect of miRNAs on fatty acid synthesis in microglia

  • Zheng, Haolin
  • Mizokami, Akiko
  • Romera-Giner, Sergio
  • Llera-Oyola, Jaime
  • Yamawaki, Yosuke
  • Sano, Tomomi
  • Jimi, Eijiro
  • García-García, Francisco
  • Kanematsu, Takashi
[EN] Background: Significant sex differences exist in the prevalence and incidence of Alzheimer's disease (AD). Notably, testosterone has been reported to regulate cognitive functions in the brain, with low serum testosterone levels correlating with increased AD risk. However, the specific mechanisms underlying this relationship remain unclear. Recent studies have demonstrated that microglia, the primary innate immune cells in the brain, play a crucial role in AD development. Therefore, this study aimed to explore sex differences in microglial function, specifically focusing on the role of testosterone in miRNA-mediated regulation of microglial gene expression. Methods: Microglia were isolated from pooled hippocampal tissue of five 8-month-old male and female mice. Total RNA was extracted and subjected to miRNA microarray analysis. The mouse microglial cell line MG6 was used for in vitro experiments. Following testosterone treatment, miRNA, gene, and protein expression levels were investigated. An inflammatory response was induced using lipopolysaccharide (LPS) stimulation, and subsequent p65 phosphorylation was assessed. Results: Sex-dependent differences were observed in miRNA-mediated biological processes, with males exhibiting greater changes. Male-enriched miRNAs were associated with fatty acid synthesis and metabolism pathways. In MG6 cells, testosterone treatment upregulated the expression of several miRNAs enriched in male microglia, particularly those targeting genes related to fatty acid synthesis. Additionally, testosterone significantly reduced the gene expression of fatty acid synthase (FASN). This testosterone-induced inhibition of FASN expression attenuated NF-¿B/p65 phosphorylation. Consequently, the suppression of FASN expression led to reduced expression and secretion of tumor necrosis factor-alpha following LPS stimulation in MG6 cells. Conclusions: These findings suggest that testosterone modulates inflammation in male microglia by regulating fatty acid synthesis, potentially contributing to the observed sex differences in AD pathogenesis., This study was supported by grants from the Japan Society for the Promotion of Science (JSPS) KAKENHI 22K09904 to AM, JST SPRING JPMJSP2136 to HZ, and PID2021-124430OA-I00 funded by MCIN/AEI/https://doi.org/10.13039/ 501100011033/ to FGG.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A single-cell meta-analysis evidences transposable element dysregulation in sex-based differences in Parkinson&apos, s disease

  • Gordillo-González, Fernando
  • Galiana-Roselló, Cristina
  • Grillo-Risco, Rubén
  • Soler-Sáez, Irene
  • Hidalgo, Marta R.
  • Siomi, Haruhiko
  • Kobayashi-Ishihara, Mie
  • García-García, Francisco
[EN] Transposable elements (TEs) (mobile genetic elements comprising ~45% of the human genome) have recently emerged as potential contributors to Parkinson's disease (PD); however their role and sex-specific impact remain poorly understood. Here, we present the first integrative meta-analysis of TE expression across 4 substantia nigra single-nucleus RNA-seq datasets, comprising a total of 66 donors, generating a cell-type-resolved atlas of TE dysregulation in PD. We identified widespread TE activation across major brain cell types (i.e. neurons, astrocytes, oligodendrocytes and microglia), with marked upregulation of L1s in neurons and HERVs in oligodendrocytes. Sex-stratified analyses revealed distinct male- and female-biased TE signatures, indicating regulatory programs uniquely affected in each sex, including MIR elements in microglia and Alu subfamilies in neurons. Correlation and genomic proximity analyses also uncovered TE-gene associations linked to important PD pathways such as neuroinflammation or myelination. Collectively, our study positions TEs as potential sex-modulated contributors to PD pathology and also provides a public web resource (PATOSS) to explore PD-associated TE transcriptional deregulation., This research was supported and partially funded by CIAICO/2023/149, CIACIF/2021/221 and CIGE/2024/242 from the Conselleria de Educacion, Cultura y Universidades de la Generalitat Valenciana; by PID2021-124430OA-I00, PID2023-146836NB-I00 and PID2025-174324OB-I00 from MICIU/AEI/10.13039/501100011033, and by ERDF/EU. Mie Kobayashi-Ishihara was supported by JSPS KAKENHI #24K09286, #25H01318, and #25H01309.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

A comprehensive transcriptional reference for severity and progression in spinal cord injury reveals novel translational biomarker genes

  • Grillo-Risco, Rubén
  • Hidalgo, Marta R.
  • Martinez-Rojas, Beatriz
  • Moreno-Manzano, Victoria
  • García-García, Francisco
[EN] Spinal cord injury (SCI) is a devastating condition that leads to motor, sensory, and autonomic dysfunction. Current therapeutic options remain limited, emphasizing the need for a comprehensive understanding of the underlying SCI-associated molecular mechanisms. This study characterized distinct SCI phases and severities at the gene and functional levels, focusing on biomarker gene identification. Our approach involved a systematic review, individual transcriptomic analysis, gene meta-analysis, and functional characterization. We compiled a total of fourteen studies with 273 samples, leading to the identification of severity- and phase-specific biomarker genes that allow the precise classification of transcriptomic profiles. We investigated the potential transferability of severity-specific biomarkers and identified a twelve-gene signature that predicted injury prognosis from human blood samples. We also report the development of MetaSCI-app - an interactive web application designed for researchers - that allows the exploration and visualization of all generated results (https://metasci-cbl.shinyapps.io/metaSCI). Overall, we present a transcriptomic reference and provide a comprehensive framework for assessing SCI considering severity and time perspectives, all integrated into a user-friendly tool., This research was supported and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF, A way to make Europe ; PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033 and by FEDER, UE; and CIAICO/2023/149 funded by the Consellería de Educación, Cultura, Universidades y Empleo de la Generalitat Valenciana.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes

  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Masia, Esther
  • Romera-Giner, Sergio
  • Malmierca-Merlo, Pablo
  • López-Guerrero, José A.
  • García-García, Francisco
  • Vicent, María J.
[EN] Identifying novel breast cancer biomarkers will improve patient stratification, enhance therapeutic outcomes, and help develop non-invasive diagnostics. We compared the proteomic profiles of whole-cell and exosomal samples of representative breast cancer cell subtypes to evaluate the potential of extracellular vesicles as non-invasive disease biomarkers in liquid biopsies. Overall, differentially-expressed proteins in whole-cell and exosome samples (which included markers for invasion, metastasis, angiogenesis, and drug resistance) effectively discriminated subtypes; furthermore, our results confirmed that the proteomic profile of exosomes reflects breast cancer cell-of-origin, which underscores their potential as disease biomarkers. Our study will contribute to identifying biomarkers that support breast cancer patient stratification and developing novel therapeutic strategies. We include an open, interactive web tool to explore the data as a molecular resource that can explain the role of these protein signatures in breast cancer classification., This study was supported by the European Research Council (grant ERC-CoG-2014-648831 MyNano ) and the H2020 EU-OpenScreen-Drive project (grant agreement No. 823893). Our screening platform is part of the European Infrastructure, ERIC EUOpenScreen, and the Excellence Network, TeNTaCLES (Translational NeTwork for the CLinical application of Extracellular Vesicle-Tentacles-RED2018-102411-T). This research was also supported by the Spanish Ministry of Science and Innovation (PID2019-108806RBI00; PID2020-117211GB-I00; PID2021-124430OA-I00 funded by MICIU/AEI/https://doi.org/10.13039/501100011033 and by FEDER, UE; and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, IMP/00019), co-funded by ERDF and CIBERONC (project n. CB22/12/00048). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia, which belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001. Agreement 2019 between IVO and the Association Mou-te per elles.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

An integrated approach to identifying sex-specific genes, transcription factors, and pathways relevant to Alzheimer&apos, s disease

  • López-Cerdán, Adolfo
  • Andreu, Zoraida
  • Hidalgo, Marta R.
  • Soler-Sáez, Irene
  • Mizokami, Akiko
  • Guerini, Franca R.
  • García-García, Francisco
  • DE LA IGLESIA VAYÁ, MARIA DE LOS DESAMPARADOS
[EN] Background: Age represents a significant risk factor for the development of Alzheimer's disease (AD); however, recent research has documented an influencing role of sex in several features of AD. Understanding the impact of sex on specific molecular mechanisms associated with AD remains a critical challenge to creating tailored therapeutic interventions. Methods: The exploration of the sex-based differential impact on disease (SDID) in AD used a systematic review to first select transcriptomic studies of AD with data regarding sex in the period covering 2002 to 2021 with a focus on the primary brain regions affected by AD - the cortex (CT) and the hippocampus (HP). A differential expression analysis for each study and two tissue-specific meta-analyses were then performed. Focusing on the CT due to the presence of significant SDID-related alterations, a comprehensive functional characterization was conducted: protein-protein network interaction and over-representation analyses to explore biological processes and pathways and a VIPER analysis to estimate transcription factor activity. Results: We selected 8 CT and 5 HP studies from the Gene Expression Omnibus (GEO) repository for tissuespecific meta-analyses. We detected 389 significantly altered genes in the SDID comparison in the CT. Generally, female AD patients displayed more affected genes than males; we grouped said genes into six subsets according to their expression profile in female and male AD patients. Only subset I (repressed genes in female AD patients) displayed significant results during functional profiling. Female AD patients demonstrated more significant impairments in biological processes related to the regulation and organization of synapsis and pathways linked to neurotransmitters (glutamate and GABA) and protein folding, A beta aggregation, and accumulation compared to male AD patients. These findings could partly explain why we observe more pronounced cognitive decline in female AD patients. Finally, we detected 23 transcription factors with different activation patterns according to sex, with some associated with AD for the first time. All results generated during this study are readily available through an open web resource Metafun-AD (https://bioinfo.cipf.es/metafun-ad/). Conclusion: Our meta-analyses indicate the existence of differences in AD-related mechanisms in female and male patients. These sex-based differences will represent the basis for new hypotheses and could significantly impact precision medicine and improve diagnosis and clinical outcomes in AD patients., This research was supported by and partially funded by the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019) , co-funded by the European Union, European Regional Development Fund (ERDF, "A way to make Europe") , and PID2021-124430OA-I00 funded by MICIU/AEI/10.13039/501100011033/and by FEDER, UE. Irene Soler-Saez ez thanks the Spanish Ministry of Universities for her predoctoral grant FPU20/03544.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

MetaOmixTools: A User-Friendly Web Suite for Meta-analysis of Ranked Features and Functional Enrichment

  • Grillo-Risco, Rubén
  • Kupchyk Tiurin, Maksym
  • Perpiñá-Clérigues, Carla
  • Cordero Felipe, Francisco J.
  • Lozano Juárez, Samuel
  • de la Iglesia-Vayá, María
  • García-García, Francisco
11 páginas, 6 figuras, The growing number of omics datasets in public repositories provides an opportunity to enhance data reusability through data integration; however, complex statistical barriers often hinder the effective combination of independent studies. To address this problem, we present MetaOmixTools, an interactive web-based suite that streamlines the meta-analysis of ranked feature lists and functional enrichment profiles. The platform integrates 2 primary modules-MetaRank and MetaEnrich-within a code-free environment. MetaRank generates robust consensus rankings from multiple lists by implementing weighted (e.g., rank product) and unweighted (e.g., robust rank aggregation) strategies, while MetaEnrich performs functional meta-analyses by combining probability values from individual overrepresentation analyses using established statistical techniques. Using case studies, we established consensus rankings for acute spinal cord injury across heterogeneous platforms, identifying conserved inflammatory marker genes in the up-regulated gene list (e.g., Slpi, Ccl2, and Msr1) and synaptic loss genes in the down-regulated gene list (e.g., Kcna2, Dao, and Ppp1r1b), and also characterized inverse functional intersections between melanoma brain metastasis and neurodegenerative diseases. By providing intuitive, real-time visualization and reproducible workflows, MetaOmixTools empowers the research community to extract consistent biological insights from multistudy data. We have made MetaOmixTools freely available at https://bioinfo.cipf.es/metaomixtools/., This research was supported and partially fundedby CIAICO/2023/149 and CIGE/2024/242 funded by the Consellería de Educación, Cultura y Universidades de la Generalitat Valenciana and PID2021-124430OA-I00 fundedby MICIU/AEI/10.13039/501100011033 and by ERDF/EU., Peer reviewed, Sin experimentacion animal ni uso de NAMs